tiprankstipranks
Trending News
More News >
KalVista Pharmaceuticals (KALV)
NASDAQ:KALV

Compare KalVista Pharmaceuticals (KALV) vs. Competitors

Compare
591 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
KalVista Pharmaceuticals
$14.60
$756.17M
-3.65
76.97%
8 Buy
0 Hold
0 Sell
Strong Buy
Savara
$5.82
$1.20B
-10.88
100.00%
6 Buy
0 Hold
0 Sell
Strong Buy
Arvinas Holding Company
$12.13
$779.04M
-15.19
-30.60%
6 Buy
3 Hold
0 Sell
Moderate Buy
Gossamer Bio
$2.52
$567.07M
-3.67
152.00%
3 Buy
1 Hold
0 Sell
Strong Buy
Compass Therapeutics
$5.70
$1.03B
-12.46
128.00%
8 Buy
0 Hold
0 Sell
Strong Buy
Bicara Therapeutics Inc.
$16.75
$914.31M
-7.51
40.99%
8 Buy
2 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
KALV
KalVista Pharmaceuticals
14.60
6.30
75.90%
SVRA
Savara
5.82
2.89
98.63%
ARVN
Arvinas Holding Company
12.20
-5.85
-32.41%
GOSS
Gossamer Bio
2.52
1.56
162.50%
CMPX
Compass Therapeutics
5.70
3.10
119.23%
BCAX
Bicara Therapeutics Inc.
16.75
4.64
38.32%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts